Your browser doesn't support javascript.
loading
Untargeted metabolomics in doping control: detection of new markers of testosterone misuse by ultrahigh performance liquid chromatography coupled to high-resolution mass spectrometry.
Raro, Montse; Ibáñez, María; Gil, Rubén; Fabregat, Andreu; Tudela, Eva; Deventer, Koen; Ventura, Rosa; Segura, Jordi; Marcos, Josep; Kotronoulas, Aristotelis; Joglar, Jesús; Farré, Magi; Yang, Sheng; Xing, Yanyi; Van Eenoo, Peter; Pitarch, Elena; Hernández, Félix; Sancho, Juan Vicente; Pozo, Óscar J.
Afiliação
  • Raro M; †Research Institute for Pesticides and Water, University Jaume I, Av. Sos Baynat S/N, 12071 Castellón, Spain.
  • Ibáñez M; †Research Institute for Pesticides and Water, University Jaume I, Av. Sos Baynat S/N, 12071 Castellón, Spain.
  • Gil R; †Research Institute for Pesticides and Water, University Jaume I, Av. Sos Baynat S/N, 12071 Castellón, Spain.
  • Fabregat A; ‡Bioanalysis Research Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Tudela E; §DoCoLab, Ghent University, Technologiepark 30, 9052, Zwijnaarde, Belgium.
  • Deventer K; §DoCoLab, Ghent University, Technologiepark 30, 9052, Zwijnaarde, Belgium.
  • Ventura R; ‡Bioanalysis Research Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Segura J; ∥Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Marcos J; ‡Bioanalysis Research Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Kotronoulas A; ∥Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Joglar J; ‡Bioanalysis Research Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Farré M; ∥Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Yang S; ‡Bioanalysis Research Group, IMIM, Hospital del Mar, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Xing Y; ⊥Department of Biological Chemistry and Molecular Modelling, Institute of Advanced Chemistry of Catalonia, Spanish Council for Scientific Research (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.
  • Van Eenoo P; ⊥Department of Biological Chemistry and Molecular Modelling, Institute of Advanced Chemistry of Catalonia, Spanish Council for Scientific Research (IQAC-CSIC), Jordi Girona 18-26, 08034 Barcelona, Spain.
  • Pitarch E; #Human Pharmacology and Neurosciences Research Group, IMIM, Clinical Pharmacology Unit, Hospital Universitari Germnans Trias I Pujol-IGTP and Universitat Autònoma de Barcelona, Doctor Aiguader 88, 08003 Barcelona, Spain.
  • Hernández F; ○National Anti-Doping Laboratory, China Anti-Doping Agency, 1, An Ding Road, Beijing, 100029, China.
  • Sancho JV; ○National Anti-Doping Laboratory, China Anti-Doping Agency, 1, An Ding Road, Beijing, 100029, China.
  • Pozo ÓJ; #Human Pharmacology and Neurosciences Research Group, IMIM, Clinical Pharmacology Unit, Hospital Universitari Germnans Trias I Pujol-IGTP and Universitat Autònoma de Barcelona, Doctor Aiguader 88, 08003 Barcelona, Spain.
Anal Chem ; 87(16): 8373-80, 2015 Aug 18.
Article em En | MEDLINE | ID: mdl-26200763
ABSTRACT
The use of untargeted metabolomics for the discovery of markers is a promising and virtually unexplored tool in the doping control field. Hybrid quadrupole time-of-flight (QTOF) and hybrid quadrupole Orbitrap (Q Exactive) mass spectrometers, coupled to ultrahigh pressure liquid chromatography, are excellent tools for this purpose. In the present work, QTOF and Q Exactive have been used to look for markers for testosterone cypionate misuse by means of untargeted metabolomics. Two different groups of urine samples were analyzed, collected before and after the intramuscular administration of testosterone cypionate. In order to avoid analyte losses in the sample treatment, samples were just 2-fold diluted with water and directly injected into the chromatographic system. Samples were analyzed in both positive and negative ionization modes. Data from both systems were treated under untargeted metabolomic strategies using XCMS application and multivariate analysis. Results from the two mass spectrometers differed in the number of detected features, but both led to the same potential marker for the particular testosterone ester misuse. The in-depth study of the MS and MS/MS behavior of this marker allowed for the establishment of 1-cyclopentenoylglycine as a feasible structure. The putative structure was confirmed by comparison with synthesized material. This potential marker seems to come from the metabolism of the cypionic acid release after hydrolysis of the administered ester. Its suitability for doping control has been evaluated.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testosterona / Cromatografia Líquida de Alta Pressão / Urinálise / Espectrometria de Massas em Tandem / Metabolômica Tipo de estudo: Diagnostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testosterona / Cromatografia Líquida de Alta Pressão / Urinálise / Espectrometria de Massas em Tandem / Metabolômica Tipo de estudo: Diagnostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article